Cellivery Therapeutics, Inc. is a company based in South Korea, with its head office in Seoul. It operates in the Research and Development in Nanotechnology industry. It was established on March 06, 2014. It currently has a total number of 1 - 10 (2025) employees. From the latest financial highlights, Cellivery Therapeutics, Inc. reported a net sales revenue drop of 18.55% in 2023. Its’ total assets recorded a negative growth of 64.39%. The net profit margin of Cellivery Therapeutics, Inc. increased by 144.1% in 2023.
Headquarters
9F, 189, Seongam-Ro, Mapo-Gu
Seoul; Seoul;
Contact Details: Purchase the Cellivery Therapeutics, Inc. report to view the information.
Website: http://www.cellivery.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service